Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Elizabeth Mary Morters has worked on the following 3 EPO patent applications which have been published in the last five years:

EP12727669

TUMOUR NECROSIS FACTOR RECEPTOR 1 ANTAGONISTS

IPC classification:
A61K 39/395, C07K 16/28
Applicant:
Glaxo Group Limited
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12744272

CATHEPSIN C INHIBITORS

IPC classification:
A01N 43/16, A61K 31/35, C07D 309/14, C07D 405/12
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11831214

BENZIMIDAZOLE DERIVATIVES AS PI3 KINASE INHIBITORS

IPC classification:
A01N 43/52, A61K 31/4164, C07D 235/08, C07D 235/10, C07D 235/24, C07D 401/10, C07D 403/04, C07D 403/10, C07D 405/04, C07D 405/10, C07D 409/10, C07D 413/04, C07D 413/10, C07D 417/04, C07D 417/10, C07D 513/04
Applicant:
GlaxoSmithKline LLC
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
PATENT GRANTED

Please Sign in to use this feature